Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the association of adipose tissue insulin resistance with longitudinal changes in biomarkers of adipose tissue function, circulating lipids, and dysglycemia. RESEARCH DESIGN AND METHODS: Adults at risk for type 2 diabetes in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort had up to four assessments over 9 years (n = 468). Adipose tissue insulin resistance was determined using a novel validated index, Adipo-IR, calculated as the product of fasting insulin and nonesterified fatty acids measured at baseline. Fasting serum was used to measure biomarkers of adipose tissue function (adiponectin and soluble CD163 [sCD163]), circulating lipids (total cholesterol, HDL, LDL, triglyceride [TG]), and systemic inflammation (interleukin-6 [IL-6] and tumor necrosis factor-α [TNF-α]). Incident dysglycemia was defined as the onset of impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes at follow-up. Generalized estimating equation (GEE) models were used to assess the relationship of Adipo-IR with longitudinal outcomes. RESULTS: GEE analyses showed that elevated Adipo-IR was longitudinally associated with adipose tissue dysfunction (adiponectin −4.20% [95% CI −6.40 to −1.95]; sCD163 4.36% [1.73–7.06], HDL −3.87% [−5.15 to −2.57], TG 9.26% [5.01–13.69]). Adipo-IR was associated with increased risk of incident dysglycemia (odds ratio 1.59 [95% CI 1.09–2.31] per SD increase). Associations remained significant after adjustment for waist circumference and surrogate indices for insulin resistance. There were no significant longitudinal associations of Adipo-IR with IL-6, TNF-α, total cholesterol, or LDL. CONCLUSIONS: Our findings demonstrate that adipose tissue insulin resistance is prospectively associated with adipose tissue function, HDL, TG, and incident dysglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The combination of high FFA flux and high insulin promotes the uptake and re-esterification of FFAs into TAGs by peripheral tissues, including the liver,11,46 and has been associated with worse histology and increased fibrosis.9,10,47”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [46]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Unwin, N. C. (2006) · Cited by 1,661
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Obesity and the role of adipose tissue in inflammation and metabolism
Greenberg, A. S., & Obin, M. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.461s · Cited by 1,273
Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Cited by
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
“…adipose tissue dysfunction stands at the forefront of the pathogenesis of insulin resistance and T2DM 4 , which starts with microenvironmental alterations that favour adipocyte apoptosis and macrophage invasion 72–74 and that transform adipose tissue function and secretion patterns 67,75,76 .”
BackgroundMeasuring and estimating insulin resistance in clinical and research settings
Gastaldelli, A. (2022) · Obesity · doi:10.1002/oby.23503 · Cited by 244
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Adipose Tissue Insulin Resistance: A Key Driver of Metabolic Syndrome Pathogenesis
Rabiee, A., Hossain, M. A., & Poojari, A. (2025) · Biomedicines · doi:10.3390/biomedicines13102376 · Cited by 63
Arner, P., Viguerie, N., Massier, L., Rydén, M., Astrup, A. V., Blaak, E. E., Langin, D., & Andersson, D. P. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01501-x · Cited by 55
Kerr, A. G., Andersson, D. P., Dahlman, I. A., Rydén, M., & Arner, P. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319227 · Cited by 50
Tong, A., Li, Z., Liu, X., Ge, X., Zhao, R., Liu, B., Zhao, L., & Zhao, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128853 · Cited by 49
Sun, H., Chang, X., Bian, N., An, Y., Liu, J., Leng, S., & Wang, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835154 · Cited by 48
Engin, B., Willis, S. A., Malaikah, S., Sargeant, J. A., Yates, T., Gray, L. J., Aithal, G. P., Stensel, D. J., & King, J. A. (2022) · Obesity Reviews · doi:10.1111/obr.13445 · Cited by 31
“It is also fundamental to the pathophysiology of type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD).(2,4,5) Within obesity, adipose tissue insulin resistance develops once an overabundance of large, hypoxic, and inflamed adipocytes are present within adipose tissue.”
BackgroundSerum Ferritin Levels Are Associated with Adipose Tissue Dysfunction-Related Indices in Obese Adults
Ding, X., Bian, N., Wang, J., Chang, X., An, Y., Wang, G., & Liu, J. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03198-3 · Cited by 28
Tarantino, G., Citro, V., & Cataldi, M. (2021) · Viruses · doi:10.3390/v13071285 · Cited by 27
“NAFLD has the potential of becoming progressive, leading to liver cirrhosis, and is associated with serious cardiometabolic abnormalities including T2DM [33] Recent findings demonstrate that insulin resistance in the adipose tissue is prospectively associated with changes in adipose tissue function (adiponectin and so…”
BackgroundIndicators of insulin resistance in clinical practice
Sasaki, N., Ueno, Y., & Higashi, Y. (2024) · Hypertension Research · doi:10.1038/s41440-023-01566-7 · Cited by 25
Triglycerides, Glucose Metabolism, and Type 2 Diabetes
Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209910 · Cited by 26
Rönn, T., Perfilyev, A., Jönsson, J., Eriksson, K., Jørgensen, S. W., Brøns, C., Gillberg, L., Vaag, A. A., Stener‐Victorin, E., & Ling, C. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad024 · Cited by 17
Zhang, B., Zhang, X., Luo, Z., Ren, J., Yu, X., Zhao, H., Wang, Y., Zhang, W., Wei-wei, T., Wei, X., et al. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.08.005 · Cited by 17
Malaikah, S., Willis, S. A., Henson, J. J., Sargeant, J. A., Yates, T. E., Thackray, A. E., Goltz, F. R., Roberts, M. J., Bodicoat, D. H., Aithal, G. P., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01350-0 · Cited by 16
“Written informed consent was obtained from all participants before partaking in these studies.”
Tang, X., Wu, R., Chen, J., Wang, F.-L., Zhao, S.-L., Lu, J. L., Qin, J., Zhuang, D., & Zhang, B. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100402 · Cited by 11
“To improve upon this, future research could integrate additional indices like QUICKI, the Matsuda Index from oral glucose tolerance tests, and the adipose tissue insulin resistance index for a more comprehensive assessment [69 – 71].”
Clusterin is closely associated with adipose tissue insulin resistance
Wang, Y., Yu, H., Ma, X., Wang, Y., Liu, W., Zhang, H., Chen, W., Song, Y., Bao, Y., & Yang, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3688 · Cited by 11
“found that Adipo‐IR was associated with increased risk of incident dysglycemia over 9 years, even after adjustment for WC and HOMA‐IR.(27) In addition, Zhang et al.”
BackgroundChen, X., Balmer, L. A., Lin, K., Cao, W., Huang, Z., Chen, X., Song, M., & Chen, Y. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00410-x · Cited by 10
Zhou, Q. G., Yan, H., Jin, A., Meng, X., Lin, J., Li, H., Wang, Y., & Pan, Y. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01235-2 · Cited by 10
“Previous research have shown the Adipo-IR may indicate adipose tissue dysfunction, and this index has shown a correlation between adipose tissue specific insulin resistance and vascular risk factors in non-stroke patients [18, 33, 34].”
BackgroundWu, C., Tiwari, A., Zlatopolsky, M., Qaqish, O., Harder, W., Blaceri, S., Saad, C., Kambhatla, S., & Kondur, A. (2025) · PubMed Central · doi:10.1097/xce.0000000000000349 · Cited by 7
“The Adipo-IR index measures the sensitivity of adipose tissue to insulin by multiplying fasting insulin by fasting FFA [22].”
Pramono, A., Kusuma, R. J., Tyas, T. A. S., Maharani, N., Rustanti, N., Noer, E. R., Lestari, E. S., & Ardiaria, M. (2026) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2026.200362 · Cited by 6
Yang, Q., Liu, X., Zhang, T., Zhao, X., & 肖小河 (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s591764 · Cited by 9
“…dysfunction in key elements such as metabolic enzymes and apolipoproteins; a typical example is the reduced activity of lipoprotein lipase in DM. 9,10 Abnormal lipid metabolism, which is present in nearly all diabetic patients and persists throughout the disease course, is a major driver of DM…”
Pepa, G. D., Carli, F., Sabatini, S., Pezzica, S., Russo, M., Vitale, M., Masulli, M., Riccardi, G., Rivellese, A. A., Vaccaro, O., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3798 · Cited by 6
“2,9 Moreover, higher values of ADIPO ‐ IR are associated with longitudinal changes in fasting plasma lipids and worsening of glucose control over time, 10 and the association was stronger than with HOMA ‐ IR.”
BackgroundCirculating BCKAs are closely associated with adipose tissue insulin resistance in type 2 diabetes
Gao, J., Rouzi, M. R. Y., Yang, H., Zheng, W., Wang, L., Lei, T., & Lu, J. K. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01860-z · Cited by 5
“Previous studies have shown that Adipo-IR were correlated with dysglycemia and increased progressively with the development of T2DM [13, 14].”
Engin, B., Willis, S. A., Malaikah, S., Sargeant, J. A., Biddle, G. J. H., Razieh, C., Argyridou, S., Edwardson, C. L., Jelleyman, C., Stensel, D. J., et al. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003193 · Cited by 6
“Given the pathophysiological link between exaggerated adipose lipolysis, ectopic lipid deposition (skeletal muscle, liver, pancreas) (16), and insulin resistance, impaired adipose tissue insulin sensitivity may mechanistically link excess sedentary time with hyperglycemia and cardiovascular disease risk.”
Backgroundβ-Cell function during a high-fat meal in young versus old adults: role of exercise
Malin, S. K., Frick, H., Wisseman, W. S., Edwards, E. S., Edwards, D. A., Emerson, S. R., & Kurti, S. P. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00047.2023 · Cited by 5
Chen, T., Wang, Z., Xie, J., Xiao, S., & Liu, N. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.04.012 · Cited by 5
Akter, T., Song, Z., Takada, M., Hamrah, M. H., Wang, S., Endale, B. T., Paththamesthrige, S. E. P., Khine, M. T., Matsunaga, M., Ota, A., et al. (2025) · Journal of Epidemiology · doi:10.2188/jea.je20250025 · Cited by 4
Sasaki, N., Ueno, Y., Ozono, R., Nakano, Y., & Higashi, Y. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117547 · Cited by 3
Zhou, Q., Cai, X., Jin, A., Jing, J., Wang, M., Wang, S., Mei, L., Meng, X., Li, S., Wei, T., et al. (2024) · Neuroepidemiology · doi:10.1159/000540321 · Cited by 2
“Persistent elevation in circulating free fatty acid was thought to be associated with a variety of downstream chain adverse effects, such as hepatic gluconeogenesis and glucose-stimulated insulin sensitivity [12].”
Kurniawan, L. B., Apriani, L. P., Kadir, N. A., Nurahmi, N., Basri, M. I., & Aminuddin, A. (2025) · PubMed Central · Cited by 3
Foreman, N. A., Rajwade, S., Bluth, J., Skoglund, L. C., Letts, A. M., DiPietro, L., Ciarleglio, A., & Barberio, M. D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00235.2025 · Cited by 1
Wei, Y., Tian, Y., Cui, R., Wang, Y., Liu, J., & Wang, G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70513 · Cited by 1
“5 In summary, adipose tissue insulin resistance is closely related to the development and progression of diabetes.”
Ge, Y., Liu, A., Meng, F., Zhang, R., Wang, J., Dang, Q., Wu, G. C., & Zhang, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7124697/v1
Oktarina, N. H., Kurniawan, L. B., Nurahmi, N., Patellongi, I. J., HUSAINI, H., & Widaningsih, Y. (2025) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.24.05761-9
Zhou, Q., Yan, H., Jin, A., Meng, X., Lin, J., Li, H., Wang, Y., & Pan, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26648574
Antsiferova, D. M., Ametov, A. S., Koteshkova, O. M. K., Ромашкина, Л. П., & Antsiferov, M. B. (2026) · Diabetes Mellitus · doi:10.14341/dm13441
Huang, J., Hong, B., Chen, X., Jiang, F., & Chen, Y. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2633804 · Cited by 2
“Adipose tissue dysfunction is at the onset of T2DM pathogenesis [97], inducing microenviron-mental alterations that are conducive to macrophage invasion and apoptosis in adipose tissue [98,99], and transforming secretion patterns [100].”
Akter, T. (2025) · Institutional Repositories DataBase (IRDB)
Numao, S., 内田, 遼., & Nakagaichi, M. (2026) · Journal of Physical Therapy Science · doi:10.1589/jpts.38.288
“However, their validity has been demonstrated in previous studies 15, 16, 28 ) , and they are widely used as practical and reliable surrogate markers in clinical and research settings 29, 30 ) .”
Chen, X. T., Tu, B. B., Li, Z., Gao, P., Xu, Y., & Yao, Y. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49873
ADIPOSE TISSUE INSULIN RESISTANCE ANALYSIS IN SUBJECTS WITH OBESITY AND NON-OBESITY
Apriani, L. P., Nurahmi, N., & Kurniawan, L. B. (2026) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v32i3.2725
Adipose tissue-on-Chip platforms for disease modelling, drug discovery and pharmacokinetic modelling
Castañé, H., Spangenberger, C., de Souza, I. R., Kristoforus, T., Lazarevski, L., Yim, J., Cipriano, M., Hjuler, S. T., Özkan, A., Petrie, T. A., et al. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115971
Zhang, Q., Chen, Y., Wang, D., Pereira, S., & Kurtyk, M. J. B. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1951400
“Consistent with these mechanisms, human studies have shown that impaired insulin-mediated suppression of adipose tissue lipolysis is associated with higher circulating triglycerides and other features of atherogenic dyslipidemia (86 – 88).”
Leiva, E. G., Barb, D., Kalavalapalli, S., Rocha, A. O., CUERVO-PARDO, N., Sharma, A., SAENZ, E. V., Lomonaco, R., MARANGI, S. A., SHETTY, S. S., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06904-1
Sasaki, N., Ueno, Y., Ozono, R., Nakano, Y., & Higashi, Y. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004466
Metadata
- Authors
- Semnani-Azad, Z., Connelly, P. W., Bazinet, R. P., Retnakaran, R., Jenkins, D. J. A., Harris, S. B., Zinman, B., & Hanley, A. J.
- Affiliations
- Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- St. Michael's Hospital (CA)
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- Western University (CA)
- Corresponding author
- Hanley, Anthony J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-05-17
- Volume
- 44
- Issue
- 7
- Pages
- 1682-1691
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3160175971
- Cited by
- 41
- References
- 45
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 4 · 2021: 1
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- adipose tissue insulin resistance, adipose tissue dysfunction, adiponectin, soluble CD163, HDL cholesterol, triglycerides, circulating lipids, dysglycemia, type 2 diabetes, impaired glucose tolerance, impaired fasting glucose, systemic inflammation, interleukin-6, TNF-α, free fatty acids, fasting insulin
- MeSH terms
- Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Lipids, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.